NHLBI Awarded Starlight Cardiovascular A $2.16M NIH SBIR Phase II Grant

NHLBI Awarded Starlight Cardiovascular A .16M NIH SBIR Phase II Grant

The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) has awarded Starlight Cardiovascular, Inc. a Small Business Innovation Research (SBIR) Phase II grant to advance the development of its Ductus Arteriosus Stent System. The grant will provide $2,158,183 to support preclinical testing of a stent designed to allow blood … Read more

Mad Rabbit announces a $10 million Series A investment

Mad Rabbit announces a  million Series A investment

Mad Rabbit Tattoo, a market leader in tattoo aftercare, has announced the successful completion of a $10 million Series A funding round led by Lucas Brand Equity, with participation from Mark Cuban, H Venture Partners, and other notable investors. With BIC’s recent acquisition of Inkbox and L’Oreal’s minority investment in Prinker Korea Inc., the funding … Read more

Flare Therapeutics Raises $123 Million Series B Financing

Flare Therapeutics Raises 3 Million Series B Financing

Flare Therapeutics Inc., a Cambridge, Massachusetts-based biotech company that targets transcription factors to discover precision medicines for cancer and other diseases, today announced a $123 million Series B financing led by GordonMD® Global Investments LP and Pfizer Ventures, with participation from existing investors Boxer Capital, Casdin Capital, Eventide Asset Management, Invus Financial Advisors, Nextech Invest, … Read more

Advantasure has been acquired by UST HealthProof

UST HealthProof, a UST company and market leader in core administrative solutions and Business-Process-as-a-Service (BPaaS) for health plans, announced today the acquisition of Advantasure, a Medicare technology solutions company. The acquisition represents the next stage of UST HealthProof’s growth as it works to revolutionize healthcare in the United States through comprehensive administrative cost-cutting solutions. UST … Read more

Frontier Received $10 million in Series A funding from AEI HorizonX

Frontier Received  million in Series A funding from AEI HorizonX

Frontier Aerospace Corporation, a pioneer in next-generation liquid rocket engines for in-space propulsion, today announced the completion of a $10 million Series A funding round led by AEI HorizonX. Frontier was established in 2014 with the goal of developing innovative space propulsion solutions. Frontier employs a tried-and-true rapid development approach that yields mission-optimized and extensively … Read more

Oleria Raises $8 million in seed funding

Oleria Raises  million in seed funding

Oleria, a security company that liberates businesses with adaptive and autonomous access solutions, has emerged from stealth mode and raised $8 million in seed funding. Salesforce Ventures led the round, with participation from Tapestry VC and angel investors including CEOs and CISOs of prominent tech and security firms. Oleria, founded by industry luminary and former … Read more

Placemakr raises $65 million, surpassing $350 million in total funding

Placemakr raises  million, surpassing 0 million in total funding

Placemakr, a flexible-use multifamily and hospitality operator, announced $65 million in new funding today, bringing its total capital raised to $350 million. This announcement coincides with the appointment of Timothy G. Franzen, former president of Graduate Hotels, to the company’s board of directors. Highland Capital Partners, Harbert Growth Partners, Bernstein Management Corporation, Camber Creek, Gaw … Read more

Gravie Received $179M Investment from General Atlantic

Gravie Received 9M Investment from General Atlantic

Gravie, one of the fastest growing employer health benefits companies in the United States, announced today that General Atlantic, a leading global growth equity investor, will lead a $179 million equity investment in the company, joining existing Gravie investors FirstMark Capital and AXA Venture Partners. Gravie intends to use the funds to fuel its ongoing … Read more

Previse Raised $3M in Seed Round

Previse Raised M in Seed Round

Previse, formerly known as Capsulomics, Inc., announced the closing of a $3 million seed round and the launch of its first laboratory-developed test, EsopredictTM. With a five-year survival rate of 20% after diagnosis, esophageal cancer is one of the most lethal cancers in the world. According to the American Cancer Society, approximately 21,560 new cases of … Read more